Skip to Content

Ryzodeg 70 / 30 Side Effects

Generic Name: insulin aspart / insulin degludec

Note: This page contains side effects data for the generic drug insulin aspart / insulin degludec. It is possible that some of the dosage forms included below may not apply to the brand name Ryzodeg 70 / 30.

For the Consumer

Applies to insulin aspart / insulin degludec: subcutaneous solution

As well as its needed effects, insulin aspart / insulin degludec may cause unwanted side effects that require medical attention.

Major Side Effects

If any of the following side effects occur while taking insulin aspart / insulin degludec, check with your doctor immediately:

More common:
  • Anxiety
  • blurred vision
  • chills
  • cold sweats
  • confusion
  • cool, pale skin
  • depression
  • dizziness
  • fast heartbeat
  • headache
  • increased hunger
  • nausea
  • nightmares
  • seizures
  • shakiness
  • slurred speech
  • unusual tiredness or weakness
Less common:
  • Bloating or swelling of the face, arms, hands, lower legs, or feet
  • rapid weight gain
  • tingling of the hands or feet
  • unusual weight gain or loss
Incidence not known:
  • Cough
  • decreased urine
  • difficulty with breathing or swallowing
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • dry mouth
  • hives, itching, or skin rash
  • increased thirst
  • irregular heartbeat
  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
  • loss of appetite
  • muscle pain or cramps
  • numbness or tingling in the hands, feet, or lips
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • reddening of the skin, especially around the ears
  • sweating
  • tightness in the chest
  • vomiting

Minor Side Effects

Some insulin aspart / insulin degludec side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:

More common:
  • Body aches or pain
  • ear congestion
  • fever
  • loss of voice
  • muscle aches
  • sneezing
  • stuffy or runny nose
Less common:
  • Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
Rare
  • Redistribution or accumulation of body fat

For Healthcare Professionals

Applies to insulin aspart / insulin degludec: subcutaneous solution

General

The most frequently reported adverse reactions include hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, pruritus, rash, edema, and weight gain.[Ref]

Metabolic

Weight gain, attributed to the anabolic effects of insulin, has been reported. In clinical trials, an average weight gain of 1.6 kg and 2.8 kg was reported in patients with type 1 diabetes and type 2 diabetes, respectively.[Ref]

Very common (10% or more): Hypoglycemia (up to 95%)
Frequency not reported: Weight gain[Ref]

Immunologic

The incidence of insulin degludec-aspart anti-insulin antibodies has not been established. The detection of antibodies is dependent on the sensitivity and specificity of the assay and may be influenced by several factors such as assay methodology, sample handling, timing of sample collection, concomitant medications, and underlying disease. Therefore, comparison of the incidence of antibodies may be misleading. In a study in patients with type 1 diabetes, almost 96% of patients were positive for insulin degludec-aspart anti-insulin antibodies at least once during the studies, including almost 89% at baseline; while 13% were positive for insulin aspart anti-insulin antibodies at least once during the studies, including 6.4% at baseline.[Ref]

Common (1% to 10%): Influenza
Frequency not reported: Anti-insulin antibodies[Ref]

Cardiovascular

Common (1% to 10%): Peripheral edema[Ref]

In clinical trials, peripheral edema was reported in 2.2% and 1.8% of patients with type 1 diabetes and type 2 diabetes, respectively.[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Hypersensitivity manifested with swelling of tongue and lips, diarrhea, nausea, tiredness and itching; urticaria[Ref]

Local

Common (1% to 10%): Injection site reactions including hematoma, pain, hemorrhage, erythema, nodules, swelling, discoloration, pruritus, warmth, and injection site mass
Uncommon (0.1% to 1%): Lipodystrophy[Ref]

Respiratory

Very common (10% or more): Nasopharyngitis (up to 24.6%)
Common (1% to 10%): Upper respiratory tract infection[Ref]

Nervous system

Common (1% to 10%): Headache

References

1. "Product Information. Ryzodeg 70 / 30 FlexTouch (insulin aspart-insulin degludec)." Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.

It is possible that some side effects of Ryzodeg 70 / 30 may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide